Studien | Der Arzneimittelbrief

ANBO2

Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-based Treatment of Hypertension in the Elderly 2

ANBP

Australian National Blood Pressure trial

ANBP2

Australian National Blood Pressure trial2

ANCHOR

Ambulatory Nisoldipine Coat-core Hypertension Outpatient Response

ANCHOR

Analysis of National COVID-19 Hospitalization Outcomes in Recipients of Aspirin

ANCHOR

ANemia in Chronic Heart failure: Outcomes and Resource utilization

ANCHOR

Anti-VEGF antibody for the treatment of predominantly classic choriodal neovascularization in age-related macular degeneration study

ANCHOR

Assessment of ECMO in Acute Myocardial Infarction Cardiogenic Shock

ANCHOR

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

ANCHOR

Evolution of Femoroacetabular Impingement Treatment

ANCHOR CRC

Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer

AND

Arbeitsgemeinschaft Niedergelassener Diabetologisch tätiger Ärzte

ANDAMAN

Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome

ANDANTE

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

ANDES

A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

ANDES

Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

ANDROMEDA

ANti-arrhythmic trial with DROnedarone in Moderate to severe CHF Evaluating morbidity DecreAse

ANDROMEDA

The Assessment of long-term clinical outcomes of de Novo DCB peRformance: a cOmprehensive, individual patient data Meta-Analysis of ranDomized clinical triAls

ANDROMEDA-SHOCK

Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study

ANDROMEDA-SHOCK-2

Hemodynamic Phenotype and Capillary Refill Time-targeted Resuscitation Strategy

Andromeda-VEXUS

Hemodynamic Phenotype and Capillary Refill Time-targeted Resuscitation Strategy (A2)

ANEMONE

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment

ANGEL

A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension

ANGEL-ASPECT

Study of Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients With a Large Infarct Core

ANGEL-REBOOT

Randomized Study of Bailout Intracranial Angioplasty Following Thrombectomy for Acute Large Vessel Occlusion

ANGEL-TNK

Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization